A detailed history of Syntax Advisors, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Syntax Advisors, LLC holds 471 shares of MCK stock, worth $247,717. This represents 0.35% of its overall portfolio holdings.

Number of Shares
471
Previous 500 5.8%
Holding current value
$247,717
Previous $213,000 4.23%
% of portfolio
0.35%
Previous 0.33%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$402.4 - $446.42 $11,669 - $12,946
-29 Reduced 5.8%
471 $204,000
Q2 2023

Aug 14, 2023

SELL
$354.01 - $427.31 $37,171 - $44,867
-105 Reduced 17.36%
500 $213,000
Q1 2023

May 15, 2023

BUY
$335.35 - $386.06 $18,108 - $20,847
54 Added 9.8%
605 $215,000
Q4 2022

Feb 14, 2023

SELL
$346.68 - $397.58 $16,293 - $18,686
-47 Reduced 7.86%
551 $206,000
Q3 2022

Nov 14, 2022

SELL
$321.25 - $373.84 $18,632 - $21,682
-58 Reduced 8.84%
598 $203,000
Q2 2022

Aug 12, 2022

SELL
$300.57 - $336.42 $10,820 - $12,111
-36 Reduced 5.2%
656 $214,000
Q1 2022

May 11, 2022

SELL
$244.61 - $310.48 $62,130 - $78,861
-254 Reduced 26.85%
692 $212,000
Q4 2021

Feb 14, 2022

BUY
$198.21 - $248.9 $187,506 - $235,459
946 New
946 $235,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $75.6B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Syntax Advisors, LLC Portfolio

Follow Syntax Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntax Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syntax Advisors, LLC with notifications on news.